NEW YORK (GenomeWeb News) – Silicon Valley Biosystems and the Mayo Clinic announced late on Monday a deal aimed at improving "accessibility and clinical utility of next-generation sequencing for patients."

The deal brings together SV Bio's genome interpretation tools and Mayo's genome reference library. Under its terms, SV Bio will provide clinical genome interpretation services and clinical decision support interfaces to Mayo. Mayo's Center for Individualized Medicine will provide clinical and laboratory expertise and support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.